Skip to main content
Clinical Trials/NCT04316247
NCT04316247
Not Yet Recruiting
N/A

Demographic, Clinicopathological Characteristics and Survival of Breast Cancer Patients in Assiut University Hospital (2015-2019).

Assiut University0 sites100 target enrollmentApril 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Carcinoma
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
The survival rate of breast cancer in assiut university hospital
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

The investigators will retrospectively study the demographic , clinicopathological characteristics and survival of breast cancer patients admitted to Assiut University hospital from the year 2015 to 2019

Detailed Description

Breast cancer is one of the most common malignancies in females, which is the second leading cause of cancer death throughout the world after lung cancer . The incidence of breast cancer has been increasing over the past decades , especially in young women (≤ 35 years old). There is approximately 182,000 women with breast neoplasm annually in the United States, accounting for about 26% of all incident cancers among women. In Asia, the morbidity rate is as high as 9.5%-12% . Even worse in China, the average onset age of breast cancer might be 8-10 years younger than that in Western countries which account for upto 4% in total breast cancer patients . In Egypt, breast cancer is the commonest type of female malignancy represented about 38.8% among common cancer sites in females.Although The unclear etiology of the majority of breast cancer, but there are numerous risk factors for the disease. Screening and early detection when combined with adequate, efficient treatment is considered the hope for a reduction of mortality in breast cancer as postulated by World Health organization (WHO).

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
December 31, 2024
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Neveen Nageh Kamel Shalaby

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • All histologically confirmed and documented patients with invasive ductal or lobular carcinoma of the breast attending at Assiut University hospital from year 2015 to 2019.

Exclusion Criteria

  • • Patients who previously received treatment outside Assiut University hospital.
  • A serious un controlled concomitant disease that would contraindicate with use of systemic treatment. .

Outcomes

Primary Outcomes

The survival rate of breast cancer in assiut university hospital

Time Frame: One year

The number of patients survived after surgery or chemotherapy

Similar Trials